Large granular lymphocyte leukemia

Current Hematologic Malignancy Reports

Volumn 2, Issue 4, 2007, Pages 278-282

  Sokol, Lubomir ^b   Loughran Jr , Thomas P ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CHLORODEOXYADENOSINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MIK BETA 1 MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; PENTOSTATIN; PURINE DERIVATIVE; TIPIFARNIB; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; BONE MARROW DEPRESSION; CANCER CHEMOTHERAPY; CHRONIC LEUKEMIA; CHRONIC NATURAL KILLER CELL LEUKEMIA; CLINICAL TRIAL; CYTOLOGY; CYTOPENIA; GENOTYPE; HUMAN; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; LARGE GRANULAR LYMPHOCYTE; LARGE GRANULAR LYMPHOCYTIC LEUKEMIA; LEUKEMIA; LYMPHOCYTOSIS; MONOTHERAPY; NATURAL KILLER CELL; PROGNOSIS; REVIEW;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC; LEUKEMIA, T-CELL; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NEUTROPENIA; OPPORTUNISTIC INFECTIONS; STEM CELL TRANSPLANTATION;

EID: 38349019593     PISSN: 15588211     EISSN: 1558822X     Source Type: Journal    
DOI: 10.1007/s11899-007-0038-7     Document Type: Review

References (39)

1. Loughran TP Jr: Clonal diseases of large granular lymphocytes. Blood 1993, 82:1-14.
2. Loughran TP Jr, Kadin ME, Starkebaum G, et al.: Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia. Ann Intern Med 1985, 102:169-175.
3. Chan WC, Catovsky D, Foucar K, et al.: T-cell large granular lymphocyte leukaemia. World Health Organization Classification of Tumors. In Pathology and Genetics of Tumors of the Haematopoietic and Lymphoid Tissues. Edited by Jaffe E, Harris N, Stein H, Vardiman J. Lyon, France: IARC Press; 2001:197-198.
4. Sokol L, Loughran TP Jr: Large granular lymphocyte leukemia. Oncologist 2006, 11:263-273.
5. Loughran TP Jr, Hadlock KG, Perzova R, et al.: Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia. Br J Haematol 1998, 101:318-324.
6. Lamy T, Liu TH, Landowski TH, et al.: Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia. Blood 1998, 92:4771-4777.
7. Schade AE, Powers JJ, Wlodarski MW, et al.: Phosphatidylinositol-3- phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis. Blood 2006, 107:4834-4840. This report demonstrates that activation of the phosphatidylinositol-3-phosphate kinase (PI-3K) pathway may inhibit apoptosis of malignant large granular lymphocytes (LGLs).
8. Epling-Burnette PK, Bai F, Wei S, et al.: ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL). Oncogene 2004, 23:9220-9229. This study showed that a constitutive activation of the ras pathway can be implicated in the pathogenesis of LGL leukemia.
9. Lamy T, Loughran TP: Large granular lymphocyte leukemia. Cancer Control 1998, 5:25-33.
10. Berliner N, Horwitz M, Loughran TP: Congenital and acquired neutropenia. Hematology Am Soc Hematol Educ Program 2004, 63-79.
11. Lacy MQ, Kurtin PJ, Tefferi A: Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities. Blood 1996, 87:3000-3006.
12. Starkebaum G, Loughran TP Jr, Gaur LK, et al.: Immunogenetic similarities between patients with Felty's syndrome and those with clonal expansions of large granular lymphocytes in rheumatoid arthritis. Arthritis Rheum 1997, 40:624-626.
13. Karadimitris A, Li K, Notaro R, et al.: Association of clonal T-cell large granular lymphocyte disease and paroxysmal nocturnal haemoglobinuria (PNH): further evidence for a pathogenetic link between T cells, aplastic anaemia and PNH. Br J Haematol 2001, 115:1010-1014.
14. Saunthararajah Y, Molldrem JL, Rivera M, et al.: Coincident myelodysplastic syndrome and T-cell large granular lymphocytic disease: clinical and pathophysiological features. Br J Haematol 2001, 112:195-200.
15. Tsukamoto N, Morita K, Maehara T, et al.: Clonality in myelodysplastic syndromes: demonstration of pluripotent stem cell origin using X-linked restriction fragment length polymorphisms. Br J Haematol 1993, 83:589-594.
16. Mongkonsritragoon W, Letendre L, Li CY: Multiple lymphoid nodules in bone marrow have the same clonality as underlying myelodysplastic syndrome recognized with fluorescent in situ hybridization technique. Am J Hematol 1998, 59:252-257.
17. Semenzato G, Zambello R, Starkebaum G, et al.: The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood 1997, 89:256-260.
18. Wong KF, Chan JC, Liu HS, et al.: Chromosomal abnormalities in T-cell large granular lymphocyte leukaemia: report of two cases and review of the literature. Br J Haematol 2002, 116:598-600.
19. Nowakowski GS, Morice WG, Zent CS, et al.: Initial presentation and prognostic factors in 286 patients with t-cell large granular lymphocyte leukemia [abstract]. Blood (ASH Annual Meeting Abstracts) 2006, 108:Abstract 300. This is the largest retrospective, single-institution study, analyzing laboratory and clinical data for 286 patients with T-cell LGL leukemia. The authors postulated the first prognostic scoring system for this disease.
20. Alekshun TJ, Sokol L: Diseases of large granular lymphocytes. Cancer Control 2007, 14:141-150.
21. Loughran TP Jr, Kidd PG, Starkebaum G: Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate. Blood 1994, 84:2164-2170.
22. Osuji N, Matutes E, Tjonnfjord G, et al.: T-cell large granular lymphocyte leukemia: a report on the treatment of 29 patients and a review of the literature. Cancer 2006, 107:570-578. This is a report of a single institution's experience with the therapy of patients with LGL leukemia.
23. Sood R, Stewart CC, Apian PD, et al.: Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cells. Blood 1998, 91:3372-3378.
24. Lamy T, LePrise PY, Amiot L, et al.: Response to granulocyte- macrophage colony-stimulating factor (GM-CSF) but not to G-CSF in a case of agranulocytosis associated with large granular lymphocyte (LGL) leukemia. Blood 1995, 85:3352-3353.
25. Witzig TE, Weitz JJ, Lundberg JH, et al.: Treatment of refractory T-cell chronic lymphocytic leukemia with purine nucleoside analogues. Leuk Lymphoma 1994, 14:137-139.
26. Rosenblum MD, LaBelle JL, Chang CC, et al.: Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukemia. Blood 2004, 103:1969-1971.
27. Aprile JA, Russo M, Pepe MS, et al.: Activation signals leading to proliferation of normal and leukemic CD3+ large granular lymphocytes. Blood 1991, 78:1282-1285.
28. Alekshun T, Tao J, Sokol L: Aggressive T-cell large granular lymphocyte leukemia. A case report and review of the literature. Am J Hematol 2007, 82:481-485. This report suggests that aggressive T-cell LGL leukemia is a distinct clinicopathologic entity in the spectrum of disorders of large granular lymphocytes.
29. Gentile TC, Uner AH, Hutchison RE, et al.: CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia. Blood 1994, 84:2315-2321.
30. Macon WR, Williams ME, Greer JP, et al.: Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes. Blood 1996, 87:1474-1483.
31. Passetto FR, Pinto SB, Garcia AB, et al.: Aggressive variant of morphologically typical T large granular lymphocyte leukemia/lymphoma lacking NK cell markers. Acta Haematol 2000, 104:110-114.
32. Tordjman R, Macintyre E, Emile JF, et al.: Aggressive acute CD3+, CD56- T cell large granular lymphocyte leukemia with two stages of maturation arrest. Leukemia 1996, 10:1514-1519.
33. Matutes E, Wotherspoon AC, Parker NE, et al.: Transformation of T-cell large granular lymphocyte leukaemia into a high-grade large T-cell lymphoma. Br J Haematol 2001, 115:801-806.
34. Zambello R, Loughran TP Jr, Trentin L, et al.: Serologic and molecular evidence for a possible pathogenetic role of viral infection in CD3-negative natural killer-type lymphoproliferative disease of granular lymphocytes. Leukemia 1995, 9:1207-1211.
35. Tefferi A, Li CY, Witzig TE, et al.: Chronic natural killer cell lymphocytosis: a descriptive clinical study. Blood 1994, 84:2721-2725.
36. Zambello R, Semenzato G: Natural killer receptors in patients with lymphoproliferative diseases of granular lymphocytes. Semin Hematol 2003, 40:201-212.
37. Chan JKC, Wong KF, Jaffe ES, et al.: Aggressive NK-cell leukemia. World Health Organization Classification of Tumors. In Pathology and Genetics of Tumors of the Haematopoietic and Lymphoid Tissues. Edited by Jaffe E, Harris N, Stein H, Vardiman J. Lyon, France: IARC Press; 2001:198-200.
38. Wong KF, Zhang YM, Chan JK: Cytogenetic abnormalities in natural killer cell lymphoma/leukaemia - Is there a consistent pattern? Leuk Lymphoma 1999, 34:241-250.
39. Okamura T, Kishimoto T, Inoue M, et al.: Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease. Bone Marrow Transplant 2003, 31:105-111.